Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
MGX

Updated 10/6/2026, 2:28 PM ET.

MGX

Metagenomi Therapeutics, Inc.

Buy$23,401

Reid Laurence

Director

20,000 shat $1.17Filed Sep 11, 7:51 PM ETFiling
MGX

Metagenomi Therapeutics, Inc.

Sale$415

Wein Matthew

See Remarks

358 shat $1.16Filed Sep 10, 3:47 PM ETFiling
MGX

Metagenomi Therapeutics, Inc.

Sale$2,479

Irish Jian

See Remarks, Director

2,140 shat $1.16Filed Sep 10, 3:40 PM ETFiling
MGX

Metagenomi Therapeutics, Inc.

Sale$2,214

Wapnick Pamela

Chief Financial Officer

1,911 shat $1.16Filed Sep 10, 3:34 PM ETFiling

Read from public SEC filings. Not financial advice.